Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer

BACKGROUND: Progression-free survival (PFS) and time to progression (TTP) are frequently used to establish the clinical efficacy of anti-cancer drugs. However, the surrogacy of PFS/TTP for overall survival (OS) remains a matter of uncertainty in metastatic breast cancer (mBC). This study assessed th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Beauchemin, Catherine, Cooper, Dan, Lapierre, Marie-Ève, Yelle, Louise, Lachaine, Jean
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2014
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069144/
https://ncbi.nlm.nih.gov/pubmed/24971020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S63302
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge